Olympus medical systems corp.(omsc) received a literature titled "usefulness of the novel snare-over-the-guidewire method for transpapillary plastic stent replacement (with video)".Literature summary: this single-center retrospective study aimed to compare the usefulness of the two methods: the snare-over-the-guidewire (sog) method and the side-of-stent (sos) method.A total of 244 patients were included (61 patients in sog group and 183 patients in sos group).In the sos group, the percentage of straight-type pss was 30.0%, while in the sog group, it was 100.0% (p < 0.001).The procedural success rate in the sog group was significantly higher than that in the sos group (90.2% vs.77.1%, p = 0.026).The time required for ps removal (seconds) was significantly shorter in the sog group than in the sos group (306 s vs.375 s, p = 0.012).Multivariate analysis also showed that the sos method (odds ratio (or) 3.64, 95% confidence interval (ci) 1.48¿10.46, p = 0.0038) and the presence of proximal biliary stenosis (or 5.08, 95% ci 2.37¿11.21, p < 0.0001).The sog method may be a very useful procedure for ps placement with possible re-intervention.Type of adverse events/number of patients post-procedure pancreatitis (1) there is no report of any olympus device malfunction in any procedure described in this study.
|
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
|